Questions about our services? (USA) 877-735-3648 Outside the US: 001-610-642-6055

February 2020 Newsletter

Ozemipic’s new indication, what does it mean for type 1 diabetes management?

Novonordisk announced an additional indication for their GLP-1 medications Ozempic to “reduce the risk of major adverse cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease."

By |2020-02-17T16:56:02-05:00February 17th, 2020|Categories: Diabetes Bites, February 2020 Newsletter|50 Comments

How Many State Medicaid Programs Cover CGM’s For People With Type 1&2 Diabetes?

February 2020 Trivia Time question. Test your knowledge about diabetes subjects and win prizes!

By |2020-02-17T17:47:07-05:00February 14th, 2020|Categories: Diabetes Bites, February 2020 Newsletter|0 Comments
Go to Top